-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LB-1908 in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LB-1908 in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LB-1908 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LB-1908 in Metastatic Adenocarcinoma of The Pancreas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LB-1908 in Metastatic Adenocarcinoma of The Pancreas report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LB-1908 in Metastatic Adenocarcinoma of The Pancreas Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AZD-5305 in Esophageal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AZD-5305 in Esophageal Cancer Drug Details: AZD-5305 is under development for the treatment of advanced...
-
Product Insights
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) – Drugs In Development, 2023
Global Markets Direct’s, ‘B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) - Drugs In Development, 2023’, provides an overview of the B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Plasma Cell Neoplasm – Drugs In Development, 2023
Global Markets Direct’s, ‘Plasma Cell Neoplasm - Drugs In Development, 2023’, provides an overview of the Plasma Cell Neoplasm pipeline landscape. The report provides comprehensive information on the therapeutics under development for Plasma Cell Neoplasm, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Analyst Opinions
Digging Deeper into Sustainability – Key Disruptive Forces in Mining (Vol.3)
Disruptive Forces in Mining Report Overview The demand for cleaner and more sustainable energy solutions such as flow batteries is rising owing to growing ESG pressure. Flow batteries have emerged as a promising technology that can contribute to a more reliable and environmentally friendly energy landscape. Leading players as well as startups are investing in developing sustainable solutions. For instance, the new kind of sodium batteries, being developed by startups such as Finland-based Broadbit and India-based AR4 Tech offer much...
-
Product Insights
Dedisa Power Plant
Dedisa Power Plant is a thermal project located in Eastern Cape, South Africa. The project is owned by Engie SA; Legend Power Solutions (Pty) Ltd; Mitsui & Co Ltd; The Peaker Trust. The project came online in 2015. Empower your strategies with our Dedisa Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
Avon Oil Fired Power Plant
Avon Oil Fired Power Plant is a thermal project located in KwaZulu-Natal, South Africa. The project is owned by Engie SA; Legend Power Solutions (Pty) Ltd; Mitsui & Co Ltd; The Peaker Trust and was developed by Engie SA. The project came online in 2016. Empower your strategies with our Avon Oil Fired Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within...